Conference Proceeding: Recent submissions
Приказ резултата 1-20 од 78
-
Immunomodulatory properties of HYCOs, NRF2 activators that simultaneously release carbon monoxide (CO) to cells and tissues
(BenBedPhar Consortium, 2023) -
Nrf2 down-regulation mediates pro-inflammatory effects of novel synthetic AhR ligands
(BenBedPhar Consortium, 2023) -
HYCO-3, an Nrf2 activator that simultaneously releases carbon monoxide (CO), ameliorates type 1 diabetes in a mouse model
(BenBedPhar Consortium, 2023) -
Evaluation of anticancer activity of Plectranthus spp. extracts
(Belgrade: Serbian Plant Physiology Society, 2018) -
Molecular biomarkers as a prognostic tool for clinical courses of experimental autoimmune encephalomyelitis in rats immunized with spinal cord homogenate
(Belgrade: Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 2023) -
Distinct clinical outcomes of Complete Freund’s adjuvant-free experimental autoimmune encephalomyelitis induced in DA rats
(Belgrade: Serbian Neuroscience Society, 2023) -
The effect of a gallic acid derivative on encephalitogenic cells
(Belgrade: Faculty of Chemistry, 2022) -
Adjuvant-free animal model for studying CNS autoimmunity
(Belgrade: Faculty of Chemistry, 2022) -
The effect of novel rosmarinic acid derivative on the pathogenesis of experimental autoimmune encephalomyelitis in rats
(Belgrade: Faculty of Chemistry, 2021) -
Development of a novel compound that upregulates Treg in the gut by modulating aryl hydrocarbon receptor's activity
(European Federation of Immunological Societies (EFIS), 2023) -
Novel aryl hydrocarbon receptor modulator promotes immunosupressive immune response by stimulating T regulatory cells in the gut
(Belgrade: Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 2023) -
Anoikis as a novel mode of shikonin derivatives anticancer action on C6 glioma cells
(Belgrade: Serbian Association for Cancer Research, 2023) -
Control of IFN-γ Responsiveness and Metastatic Potential in Melanoma by GSTA4
(Belgrade: Serbian Association for Cancer Research, 2023) -
Повећана експресија GSTA4 у меланому подстиче избегавање антитуморског имунског одговора и повећава метастатски потенцијал / GSTA4 upregulation promotes melanoma immune evasion and metastasis
(Kragujevac: Serbian Society for Immunology, Molecular Oncology and Regenerative Medicine, 2023) -
Нутрацеутици хмеља у сусрет терапији метастатског меланома / Nutraceuticals from hops in the treatment of metastatic melanoma
(Kragujevac: Serbian Society for Immunology, Molecular Oncology and Regenerative Medicine, 2023) -
Tамоксифен као вектор за платинске(II) и паладијумске(II) комплексе у третману рака дојке / Tamoxifen as a vector for platinum(II) and palladium(II) complexes in breast cancer treatment
(Kragujevac: Serbian Society for Immunology, Molecular Oncology and Regenerative Medicine, 2023) -
In vitro биолошка евалуација аналога di-tert-бутилфенола на бази p-карборана / In vitro biological evaluation of p-carborane-based di-tert-butylphenol analogs
(Kragujevac: Serbian Society for Immunology, Molecular Oncology and Regenerative Medicine, 2023) -
Aнтитуморски потенцијал изонимесулида и његових деривата карборана / Antitumor potential of isonimesulide and its carborane derivatives
(Kragujevac: Serbian Society for Immunology, Molecular Oncology and Regenerative Medicine, 2023) -
Potential of Tamoxifen-based Copper(II) Dichloride in Breast Cancer Therapy
(Belgrade: Serbian Association for Cancer Research, 2023) -
Anticancer activity of diphenyltin(IV) compounds bearing carboxylato N-functionalized 2-quinolones
(Belgrade: Serbian Association for Cancer Research, 2023)